Outcome analysis of ledipasvir/sofosbuvir (LDV/SOF) for the treatment of chronic hepatitis C infected genotype 1 patients in the UK.

Conference Reports for NATAP

AASLD/EASL Special Conference
on Hepatitis C
New York City, New York
September 12 - 13


Outcome analysis of ledipasvir/sofosbuvir (LDV/SOF) for the treatment of chronic hepatitis C infected genotype 1 patients in the UK.

	Reported by Jules Levin AASLD/EASL Special Conference NY Sept 2014 Ines Guerra1, Sandrine Cure1, Lucile Marie1, Geoffrey Dusheiko2 \| 1OptumInsight, Uxbridge, UK; 2UCL Institute for Liver and Digestive health, Royal free hospital